Orum Therapeutics is a biotech company creating cell-penetrating therapeutic antibodies. It develops Oromab, a cell-specific, cell-penetrating antibody platform technology that targets “undruggable” proteins and delivers a variety of therapeutic payloads. The company is applying the platform to discover and develop novel therapeutics for cancer and rare diseases, both internally and with partners.